OmsætningOverskudP/EKUVEBITUdbytteAktierMarkedsværdiGældForpligtelserEgenkapitalAAQSMedarbejdereROEROAROCE

Smart Eye AB (publ) AAQS 2024

Smart Eye AB (publ) AAQS

6

Smart Eye AB (publ) Udbytterendite

Ticker

SEYE.ST

ISIN

SE0009268279

WKN

A2DGQ5

Smart Eye AB (publ) har en aktuel AAQS på 6. En høj AAQS kan betragtes som et positivt tegn på, at virksomheden udvikler sig succesfuldt. Investorerne kan forvente, at virksomheden er på rette spor mod at skabe overskud. På den anden side er det vigtigt at betragte AAQS for aktien Smart Eye AB (publ) i forhold til de opnåede overskud og sammenligne med andre virksomheder i samme branche. En høj AAQS er ikke en absolut garanti for en positiv fremtid. Det er kun på den måde, man kan få et komplet billede af virksomhedens præstationer. For bedre at kunne vurdere virksomhedens udvikling er det vigtigt at betragte AAQS i sammenligning med andre virksomheder i samme branche. Generelt bør investorer altid betragte en virksomheds AAQS i sammenhæng med andre nøgletal som overskud, EBIT, cash flow og andre for at træffe en velbaseret investeringsbeslutning.

Smart Eye AB (publ) Aktienanalyse

Hvad gør Smart Eye AB (publ)?

Smart Eye AB (publ) was founded in Sweden in 1999 and is a leading provider of eye-tracking technologies. The company is listed on the Nasdaq Stockholm Stock Exchange and offers products and services for eye movement analysis, biometric identification, vehicle safety, and medicine. The main activity of Smart Eye is to develop and sell eye-tracking technologies, specifically systems that use cameras to record which areas of a screen surface a person is looking at. This can be used to optimize websites or advertisement banners, for example. Another application of eye-tracking technologies is biometric identification, where a person's eye movements are recorded to verify their identity. This is particularly used in the field of IT security. Another important business field for Smart Eye is vehicle safety. The company has developed special camera systems that record the driver's eye movements. This can be used, for example, to detect signs of fatigue or distraction. This technology is used by car manufacturers such as Audi, General Motors, and Jaguar Land Rover. Smart Eye is also active in the field of medicine. The company has developed a technology that records the eye movements of children to detect developmental disorders at an early stage. This technology is used by clinics and doctors in Europe and the USA. Overall, Smart Eye has filed numerous patents and is active in various sectors. The company has around 150 employees and is represented in several countries. The history of Smart Eye began in 1999 when the founders, Martin Krantz and Anders Lyrheden, had the idea to develop a technology that could analyze eye movements. At that time, the technology was still very new and there were hardly any providers on the market. The first product of Smart Eye, the Eye Tracker System, was launched in 2000. It was a camera system that could record the eye movements of people. In the following years, Smart Eye received numerous awards for its technologies. For example, the company was awarded the Swedish Innovation Prize in 2002. Due to the growing interest in eye-tracking technologies, Smart Eye expanded into other countries, including the USA and China. In 2016, Smart Eye went public on the Nasdaq Stockholm Stock Exchange. This allowed the company to increase its capital and make further investments. The following year, Smart Eye opened a research center in Canada to strengthen its research and development activities. In recent years, Smart Eye has introduced numerous new products and technologies to the market. In 2017, new camera systems for vehicle safety were introduced. These not only captured the driver's eye movements but also those of other passengers. In 2019, Smart Eye launched a new product for use in medicine. This is an eye-tracking system that records the eye movements of children to detect developmental disorders at an early stage. Answer: Smart Eye AB (publ) was founded in Sweden in 1999 and is a leading provider of eye-tracking technologies. The company is listed on the Nasdaq Stockholm Stock Exchange and offers products and services for eye movement analysis, biometric identification, vehicle safety, and medicine. Smart Eye AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Ofte stillede spørgsmål om Smart Eye AB (publ) aktien

Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.

Andere Kennzahlen von Smart Eye AB (publ)

Vores aktieanalyse af Smart Eye AB (publ) Omsætning-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Smart Eye AB (publ) Omsætning. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: